Scientific article

Oncogene-induced senescence: the bright and dark side of the response

Published inCurrent opinion in cell biology, vol. 22, no. 6, p. 816-827
Publication date2010-12
First online date2010-09-16

In late 1990s, it was shown that activated oncogenes are able to induce senescence. Since then large leaps in understanding this phenomenon have been achieved. There is substantial evidence supporting oncogene-induced senescence (OIS) as a potent antitumor barrier in vivo. Multiple pathways participating in cell cycle regulation, DNA damage signaling, immune response, and bioenergetics regulate the process. Despite its beneficial effects the senescent cell is thought to promote carcinogenesis and age-related disease in a nonautonomous manner. Here, we highlight the works dealing with all these aspects and discuss the studies proposing therapeutic exploitation of OIS.

Research group
Citation (ISO format)
GORGOULIS, Vassilis G., HALAZONETIS, Thanos. Oncogene-induced senescence: the bright and dark side of the response. In: Current opinion in cell biology, 2010, vol. 22, n° 6, p. 816–827. doi: 10.1016/j.ceb.2010.07.013
Main files (1)
Article (Published version)
ISSN of the journal0955-0674

Technical informations

Creation01/03/2024 8:50:30 AM
First validation02/07/2024 10:30:02 AM
Update time02/07/2024 10:36:21 AM
Status update02/07/2024 10:36:21 AM
Last indexation02/07/2024 10:36:23 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack